Publikationen, an denen er mitarbeitet JOSÉ MARÍA AGUADO GARCÍA (9)

2023

  1. A machine learning tool for the diagnosis of SARS-CoV-2 infection from hemogram parameters

    Journal of Cellular and Molecular Medicine, Vol. 27, Núm. 22, pp. 3423-3430

2022

  1. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  2. Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19

    Biomedicines, Vol. 10, Núm. 3

2021

  1. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  2. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  3. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies

    European Journal of Haematology, Vol. 105, Núm. 5, pp. 597-607

  2. IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection

    Annals of Hematology

  3. IL-6–based mortality risk model for hospitalized patients with COVID-19

    Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 4, pp. 799-807.e9